Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management under the brand name Mounjaro and for chronic weight management as Zepbound
The severity of the vitamin B12 deficiency Presence of underlying health conditions Patients response to initial treatment Age and weight considerations Healthcare providers can adjust the vitamin B12 injection dosage based on these factors
This practical "test-treat-retest" approach provides clear data on whether the oral route is working for you
Unlike hGH, it does not interact with the hGH receptor, avoiding effects on IGF-1 levels or insulin sensitivity
This may be relevant to some people following a vegan or very restricted diet, but diet should not be assumed to be the cause without considering symptoms, medicines, surgery and other risk factors
The patient requires a structured loading-dose schedule followed by ongoing injections